Concepedia

Publication | Open Access

MicroRNA miR-155 is a biomarker of early pancreatic neoplasia

DOIFull Paper Access

297

Citations

35

References

2009

Year

Nils Habbe, Jan-Bart M. Koorstra, Joshua T. Mendell, G. Johan A. Offerhaus, Ji Kon Ryu, Georg Feldmann, Michael E. Mullendore, Michael Goggins, Seung‐Mo Hong, Anirban Maitra
Cancer Biology & Therapy

Abstract

Aberrant miRNA expression is an early event in the multistage progression of pancreatic cancer, and miR-155 warrants further evaluation as a biomarker for IPMNs in clinical samples.

References

YearCitations

Page 1